HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuro Uchida Selected Research

Hepatitis B

1/2023Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL.
1/2021Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection-Pilot study.
12/2018Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.
1/2017Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.
10/2015Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuro Uchida Research Topics

Disease

23Infections
01/2023 - 01/2015
9Chronic Hepatitis B
01/2019 - 01/2016
7Chronic Hepatitis C
01/2021 - 02/2016
5Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2018
5Hepatitis B
01/2023 - 10/2015
3Chronic Hepatitis (Chronic Active Hepatitis)
01/2023 - 12/2018
3Hepatitis
01/2021 - 12/2018
2Acute-On-Chronic Liver Failure
10/2023 - 10/2023
2Acute Liver Failure (Fulminant Hepatic Failure)
09/2023 - 10/2015
2Non-alcoholic Fatty Liver Disease
04/2023 - 01/2019
2Inflammation (Inflammations)
01/2022 - 07/2019
2Disease Progression
12/2021 - 07/2019
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2017 - 01/2017
1Hepatic Encephalopathy
09/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2023
1Ulcerative Colitis
01/2022
1Wounds and Injuries (Trauma)
01/2021
1Coinfection
01/2020
1Fibrosis (Cirrhosis)
01/2019
1Necrosis
01/2018
1Neoplasms (Cancer)
01/2018
1Diarrhea
01/2018
1Edema (Dropsy)
08/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2016

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
01/2023 - 09/2015
6Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2023 - 01/2017
6InterferonsIBA
01/2019 - 09/2015
5daclatasvirIBA
01/2020 - 01/2015
5asunaprevirIBA
01/2020 - 01/2015
5AntigensIBA
01/2019 - 10/2015
4NucleotidesIBA
01/2023 - 01/2018
3CytokinesIBA
09/2023 - 01/2018
3Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
01/2021 - 10/2015
3NucleosidesIBA
01/2019 - 01/2018
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
10/2023 - 10/2023
2Interleukin-8 (Interleukin 8)IBA
09/2023 - 12/2018
2Prothrombin (Factor II)IBA
09/2023 - 01/2021
2Complementary DNA (cDNA)IBA
01/2023 - 05/2017
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2019
2lenvatinibIBA
01/2023 - 01/2022
2ChemokinesIBA
07/2019 - 01/2018
2entecavirFDA Link
12/2018 - 01/2018
2HMGB1 Protein (HMG1)IBA
01/2018 - 01/2018
2Sorafenib (BAY 43-9006)FDA Link
01/2018 - 01/2018
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2017 - 01/2017
1Interleukin-4 (Interleukin 4)IBA
09/2023
1Chloroform (Trichloromethane)IBA
04/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1atezolizumabIBA
01/2023
1HLA-A24 AntigenIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
06/2022
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2022
1FlagellinIBA
01/2022
1Taurocholic Acid (Sodium Taurocholate)IBA
12/2021
1SodiumIBA
12/2021
1Peptides (Polypeptides)IBA
12/2021
1Abatacept (Orencia)FDA Link
01/2021
1GlucocorticoidsIBA
01/2021
1MethylprednisoloneFDA LinkGeneric
01/2021
1glecaprevir and pibrentasvirIBA
01/2021
1Ribavirin (Virazole)FDA LinkGeneric
01/2020
1IntegrinsIBA
07/2019
1pibrentasvirIBA
03/2019
1glecaprevirIBA
03/2019
1Hepatitis B e AntigensIBA
01/2018
1Fetal Proteins (Fetoprotein)IBA
01/2018
1Alanine Transaminase (SGPT)IBA
01/2018
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
01/2018
1chlorcyclizineIBA
01/2018
1LuciferasesIBA
01/2018
1Interferon-betaIBA
01/2017
1SimeprevirIBA
12/2016
1Protease Inhibitors (Protease Inhibitor)IBA
12/2016
1VaccinesIBA
11/2016
1CreatinineIBA
08/2016
1Tenofovir (Viread)FDA Link
01/2016
1Interferon LambdaIBA
09/2015

Therapy/Procedure

17Therapeutics
01/2023 - 01/2015
4Liver Transplantation
09/2023 - 10/2015
3Drug Therapy (Chemotherapy)
06/2022 - 01/2018
1Transplantation
01/2023
1Complementary Therapies (Alternative Medicine)
01/2021